Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study
Obective The aim of this study was to report outcomes following percutaneous microwave and cryoablation of lung metastases from adenoid cystic carcinoma (ACC) of the head and neck. Material and Methods This bi-institutional retrospective cohort study included 10 patients (6 females, median age 59 ye...
Gespeichert in:
| Veröffentlicht in: | Annals of surgical oncology 2021-10, Vol.28 (11), p.5829-5839 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5839 |
|---|---|
| container_issue | 11 |
| container_start_page | 5829 |
| container_title | Annals of surgical oncology |
| container_volume | 28 |
| creator | Leppelmann, Konstantin S. Levesque, Vincent M. Bunck, Alexander C. Cahalane, Alexis M. Lanuti, Michael Silverman, Stuart G. Shyn, Paul B. Fintelmann, Florian J. |
| description | Obective
The aim of this study was to report outcomes following percutaneous microwave and cryoablation of lung metastases from adenoid cystic carcinoma (ACC) of the head and neck.
Material and Methods
This bi-institutional retrospective cohort study included 10 patients (6 females, median age 59 years [range 28–81]) who underwent 32 percutaneous ablation sessions (21 cryoablation, 11 microwave) of 60 lung metastases (median 3.5 tumors per patient [range 1–16]) from 2007 to 2019. Median tumor diameter was 16 mm [range 7–40], significantly larger for cryoablation (22 mm,
p
= 0.002). A median of two tumors were treated per session [range 1–7]. Technical success, local control, complications, and overall survival were assessed.
Results
Primary technical success was achieved for 55/60 tumors (91.7%). Median follow-up was 40.6 months (clinical) and 32.5 months (imaging, per tumor). Local control at 1, 2, and 3 years was 94.7%, 80.8%, and 76.4%, respectively, and did not differ between ablation modalities. Five of fifteen recurrent tumors underwent repeat ablation, and secondary technical success was achieved in four (80%). Assisted local tumor control at 1, 2, and 3 years was 96.2%, 89.8%, and 84.9%, respectively. Complications occurred following 24/32 sessions (75.0%) and 63.2% Common Terminology Criteria for Adverse Events (CTCAE) lower than grade 3. Of 13 pneumothoraces, 7 required chest tube placements. Hemoptysis occurred after 7/21 cryoablation sessions, and bronchopleural fistula developed more frequently with microwave (
p
= 0.037). Median length of hospital stay was 1 day [range 0–10], and median overall survival was 81.5 months (IQR 40.4–93.1).
Conclusion
Percutaneous computed tomography-guided microwave and cryoablation can treat lung metastases from ACC of the head and neck. Complications are common but manageable, with full recovery expected. |
| doi_str_mv | 10.1245/s10434-021-09714-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2492662096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2575670564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-99a22effc72c71da65de749c7d4835c45532a51e3109c986de6564d9c10e3a7b3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhSMEog_4AyyQJTZsAn57wm6IKK00pYjHOvLYN61LEk9th2p-Vf8idzoFJBZIlmzZ3zlXPqeqXjD6hnGp3mZGpZA15aymjWGylo-qQ6bwSuoFe4xnqhd1w7U6qI5yvqaUGUHV0-pACM2pZvqwuruYi4sjZHIShyHehumSfIbk5mIniHMm58GleGt_ArGTJ23aRrsebAlxIrEnqxn5cyg240KTPsWRLD1MMSC8zSU40trkwhRHuxOUKyCnYP292ydwP96RJXkf6rMJ2TLvfO1AvkBJMW_AlYCD23gVUyFfy-y3z6onvR0yPH_Yj6vvJx--taf16uLjWbtc1U4YVeqmsZxD3zvDnWHeauXByMYZLxdCOamU4FYxEIw2rlloD1pp6RvHKAhr1uK4er333aR4M0Mu3Riyg2HYx9JxibliiI1G9NU_6HWcE34DKWWUNhStkeJ7CuPMOUHfbVIYbdp2jHa7Ort9nR3W2d3X2e1ELx-s5_UI_o_kd38IiD2Q8Wm6hPR39n9sfwEei6za</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2575670564</pqid></control><display><type>article</type><title>Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Leppelmann, Konstantin S. ; Levesque, Vincent M. ; Bunck, Alexander C. ; Cahalane, Alexis M. ; Lanuti, Michael ; Silverman, Stuart G. ; Shyn, Paul B. ; Fintelmann, Florian J.</creator><creatorcontrib>Leppelmann, Konstantin S. ; Levesque, Vincent M. ; Bunck, Alexander C. ; Cahalane, Alexis M. ; Lanuti, Michael ; Silverman, Stuart G. ; Shyn, Paul B. ; Fintelmann, Florian J.</creatorcontrib><description>Obective
The aim of this study was to report outcomes following percutaneous microwave and cryoablation of lung metastases from adenoid cystic carcinoma (ACC) of the head and neck.
Material and Methods
This bi-institutional retrospective cohort study included 10 patients (6 females, median age 59 years [range 28–81]) who underwent 32 percutaneous ablation sessions (21 cryoablation, 11 microwave) of 60 lung metastases (median 3.5 tumors per patient [range 1–16]) from 2007 to 2019. Median tumor diameter was 16 mm [range 7–40], significantly larger for cryoablation (22 mm,
p
= 0.002). A median of two tumors were treated per session [range 1–7]. Technical success, local control, complications, and overall survival were assessed.
Results
Primary technical success was achieved for 55/60 tumors (91.7%). Median follow-up was 40.6 months (clinical) and 32.5 months (imaging, per tumor). Local control at 1, 2, and 3 years was 94.7%, 80.8%, and 76.4%, respectively, and did not differ between ablation modalities. Five of fifteen recurrent tumors underwent repeat ablation, and secondary technical success was achieved in four (80%). Assisted local tumor control at 1, 2, and 3 years was 96.2%, 89.8%, and 84.9%, respectively. Complications occurred following 24/32 sessions (75.0%) and 63.2% Common Terminology Criteria for Adverse Events (CTCAE) lower than grade 3. Of 13 pneumothoraces, 7 required chest tube placements. Hemoptysis occurred after 7/21 cryoablation sessions, and bronchopleural fistula developed more frequently with microwave (
p
= 0.037). Median length of hospital stay was 1 day [range 0–10], and median overall survival was 81.5 months (IQR 40.4–93.1).
Conclusion
Percutaneous computed tomography-guided microwave and cryoablation can treat lung metastases from ACC of the head and neck. Complications are common but manageable, with full recovery expected.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-021-09714-4</identifier><identifier>PMID: 33620616</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Ablation ; Adenoid ; Adult ; Adverse events ; Aged ; Aged, 80 and over ; Carcinoma, Adenoid Cystic - surgery ; Cohort analysis ; Computed tomography ; Cryosurgery ; Female ; Head and neck carcinoma ; Head and Neck Oncology ; Hemoptysis ; Humans ; Kidney Neoplasms - surgery ; Lung cancer ; Lung Neoplasms - surgery ; Medicine ; Medicine & Public Health ; Metastases ; Metastasis ; Microwaves - therapeutic use ; Middle Aged ; Neoplasm Recurrence, Local - surgery ; Oncology ; Patients ; Retrospective Studies ; Success ; Surgery ; Surgical Oncology ; Survival ; Terminology ; Treatment Outcome ; Tumors</subject><ispartof>Annals of surgical oncology, 2021-10, Vol.28 (11), p.5829-5839</ispartof><rights>Society of Surgical Oncology 2021. corrected publication 2022</rights><rights>2021. Society of Surgical Oncology.</rights><rights>Society of Surgical Oncology 2021. corrected publication 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-99a22effc72c71da65de749c7d4835c45532a51e3109c986de6564d9c10e3a7b3</citedby><cites>FETCH-LOGICAL-c375t-99a22effc72c71da65de749c7d4835c45532a51e3109c986de6564d9c10e3a7b3</cites><orcidid>0000-0002-0119-3903</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-021-09714-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-021-09714-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33620616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leppelmann, Konstantin S.</creatorcontrib><creatorcontrib>Levesque, Vincent M.</creatorcontrib><creatorcontrib>Bunck, Alexander C.</creatorcontrib><creatorcontrib>Cahalane, Alexis M.</creatorcontrib><creatorcontrib>Lanuti, Michael</creatorcontrib><creatorcontrib>Silverman, Stuart G.</creatorcontrib><creatorcontrib>Shyn, Paul B.</creatorcontrib><creatorcontrib>Fintelmann, Florian J.</creatorcontrib><title>Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Obective
The aim of this study was to report outcomes following percutaneous microwave and cryoablation of lung metastases from adenoid cystic carcinoma (ACC) of the head and neck.
Material and Methods
This bi-institutional retrospective cohort study included 10 patients (6 females, median age 59 years [range 28–81]) who underwent 32 percutaneous ablation sessions (21 cryoablation, 11 microwave) of 60 lung metastases (median 3.5 tumors per patient [range 1–16]) from 2007 to 2019. Median tumor diameter was 16 mm [range 7–40], significantly larger for cryoablation (22 mm,
p
= 0.002). A median of two tumors were treated per session [range 1–7]. Technical success, local control, complications, and overall survival were assessed.
Results
Primary technical success was achieved for 55/60 tumors (91.7%). Median follow-up was 40.6 months (clinical) and 32.5 months (imaging, per tumor). Local control at 1, 2, and 3 years was 94.7%, 80.8%, and 76.4%, respectively, and did not differ between ablation modalities. Five of fifteen recurrent tumors underwent repeat ablation, and secondary technical success was achieved in four (80%). Assisted local tumor control at 1, 2, and 3 years was 96.2%, 89.8%, and 84.9%, respectively. Complications occurred following 24/32 sessions (75.0%) and 63.2% Common Terminology Criteria for Adverse Events (CTCAE) lower than grade 3. Of 13 pneumothoraces, 7 required chest tube placements. Hemoptysis occurred after 7/21 cryoablation sessions, and bronchopleural fistula developed more frequently with microwave (
p
= 0.037). Median length of hospital stay was 1 day [range 0–10], and median overall survival was 81.5 months (IQR 40.4–93.1).
Conclusion
Percutaneous computed tomography-guided microwave and cryoablation can treat lung metastases from ACC of the head and neck. Complications are common but manageable, with full recovery expected.</description><subject>Ablation</subject><subject>Adenoid</subject><subject>Adult</subject><subject>Adverse events</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma, Adenoid Cystic - surgery</subject><subject>Cohort analysis</subject><subject>Computed tomography</subject><subject>Cryosurgery</subject><subject>Female</subject><subject>Head and neck carcinoma</subject><subject>Head and Neck Oncology</subject><subject>Hemoptysis</subject><subject>Humans</subject><subject>Kidney Neoplasms - surgery</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - surgery</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Microwaves - therapeutic use</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>Oncology</subject><subject>Patients</subject><subject>Retrospective Studies</subject><subject>Success</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival</subject><subject>Terminology</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtv1DAUhSMEog_4AyyQJTZsAn57wm6IKK00pYjHOvLYN61LEk9th2p-Vf8idzoFJBZIlmzZ3zlXPqeqXjD6hnGp3mZGpZA15aymjWGylo-qQ6bwSuoFe4xnqhd1w7U6qI5yvqaUGUHV0-pACM2pZvqwuruYi4sjZHIShyHehumSfIbk5mIniHMm58GleGt_ArGTJ23aRrsebAlxIrEnqxn5cyg240KTPsWRLD1MMSC8zSU40trkwhRHuxOUKyCnYP292ydwP96RJXkf6rMJ2TLvfO1AvkBJMW_AlYCD23gVUyFfy-y3z6onvR0yPH_Yj6vvJx--taf16uLjWbtc1U4YVeqmsZxD3zvDnWHeauXByMYZLxdCOamU4FYxEIw2rlloD1pp6RvHKAhr1uK4er333aR4M0Mu3Riyg2HYx9JxibliiI1G9NU_6HWcE34DKWWUNhStkeJ7CuPMOUHfbVIYbdp2jHa7Ort9nR3W2d3X2e1ELx-s5_UI_o_kd38IiD2Q8Wm6hPR39n9sfwEei6za</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Leppelmann, Konstantin S.</creator><creator>Levesque, Vincent M.</creator><creator>Bunck, Alexander C.</creator><creator>Cahalane, Alexis M.</creator><creator>Lanuti, Michael</creator><creator>Silverman, Stuart G.</creator><creator>Shyn, Paul B.</creator><creator>Fintelmann, Florian J.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0119-3903</orcidid></search><sort><creationdate>20211001</creationdate><title>Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study</title><author>Leppelmann, Konstantin S. ; Levesque, Vincent M. ; Bunck, Alexander C. ; Cahalane, Alexis M. ; Lanuti, Michael ; Silverman, Stuart G. ; Shyn, Paul B. ; Fintelmann, Florian J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-99a22effc72c71da65de749c7d4835c45532a51e3109c986de6564d9c10e3a7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Ablation</topic><topic>Adenoid</topic><topic>Adult</topic><topic>Adverse events</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma, Adenoid Cystic - surgery</topic><topic>Cohort analysis</topic><topic>Computed tomography</topic><topic>Cryosurgery</topic><topic>Female</topic><topic>Head and neck carcinoma</topic><topic>Head and Neck Oncology</topic><topic>Hemoptysis</topic><topic>Humans</topic><topic>Kidney Neoplasms - surgery</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - surgery</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Microwaves - therapeutic use</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>Oncology</topic><topic>Patients</topic><topic>Retrospective Studies</topic><topic>Success</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival</topic><topic>Terminology</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leppelmann, Konstantin S.</creatorcontrib><creatorcontrib>Levesque, Vincent M.</creatorcontrib><creatorcontrib>Bunck, Alexander C.</creatorcontrib><creatorcontrib>Cahalane, Alexis M.</creatorcontrib><creatorcontrib>Lanuti, Michael</creatorcontrib><creatorcontrib>Silverman, Stuart G.</creatorcontrib><creatorcontrib>Shyn, Paul B.</creatorcontrib><creatorcontrib>Fintelmann, Florian J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leppelmann, Konstantin S.</au><au>Levesque, Vincent M.</au><au>Bunck, Alexander C.</au><au>Cahalane, Alexis M.</au><au>Lanuti, Michael</au><au>Silverman, Stuart G.</au><au>Shyn, Paul B.</au><au>Fintelmann, Florian J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>28</volume><issue>11</issue><spage>5829</spage><epage>5839</epage><pages>5829-5839</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Obective
The aim of this study was to report outcomes following percutaneous microwave and cryoablation of lung metastases from adenoid cystic carcinoma (ACC) of the head and neck.
Material and Methods
This bi-institutional retrospective cohort study included 10 patients (6 females, median age 59 years [range 28–81]) who underwent 32 percutaneous ablation sessions (21 cryoablation, 11 microwave) of 60 lung metastases (median 3.5 tumors per patient [range 1–16]) from 2007 to 2019. Median tumor diameter was 16 mm [range 7–40], significantly larger for cryoablation (22 mm,
p
= 0.002). A median of two tumors were treated per session [range 1–7]. Technical success, local control, complications, and overall survival were assessed.
Results
Primary technical success was achieved for 55/60 tumors (91.7%). Median follow-up was 40.6 months (clinical) and 32.5 months (imaging, per tumor). Local control at 1, 2, and 3 years was 94.7%, 80.8%, and 76.4%, respectively, and did not differ between ablation modalities. Five of fifteen recurrent tumors underwent repeat ablation, and secondary technical success was achieved in four (80%). Assisted local tumor control at 1, 2, and 3 years was 96.2%, 89.8%, and 84.9%, respectively. Complications occurred following 24/32 sessions (75.0%) and 63.2% Common Terminology Criteria for Adverse Events (CTCAE) lower than grade 3. Of 13 pneumothoraces, 7 required chest tube placements. Hemoptysis occurred after 7/21 cryoablation sessions, and bronchopleural fistula developed more frequently with microwave (
p
= 0.037). Median length of hospital stay was 1 day [range 0–10], and median overall survival was 81.5 months (IQR 40.4–93.1).
Conclusion
Percutaneous computed tomography-guided microwave and cryoablation can treat lung metastases from ACC of the head and neck. Complications are common but manageable, with full recovery expected.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>33620616</pmid><doi>10.1245/s10434-021-09714-4</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-0119-3903</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9265 |
| ispartof | Annals of surgical oncology, 2021-10, Vol.28 (11), p.5829-5839 |
| issn | 1068-9265 1534-4681 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2492662096 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Ablation Adenoid Adult Adverse events Aged Aged, 80 and over Carcinoma, Adenoid Cystic - surgery Cohort analysis Computed tomography Cryosurgery Female Head and neck carcinoma Head and Neck Oncology Hemoptysis Humans Kidney Neoplasms - surgery Lung cancer Lung Neoplasms - surgery Medicine Medicine & Public Health Metastases Metastasis Microwaves - therapeutic use Middle Aged Neoplasm Recurrence, Local - surgery Oncology Patients Retrospective Studies Success Surgery Surgical Oncology Survival Terminology Treatment Outcome Tumors |
| title | Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A57%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20Following%20Percutaneous%20Microwave%20and%20Cryoablation%20of%20Lung%20Metastases%20from%20Adenoid%20Cystic%20Carcinoma%20of%20the%20Head%20and%20Neck:%20A%20Bi-Institutional%20Retrospective%20Cohort%20Study&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Leppelmann,%20Konstantin%20S.&rft.date=2021-10-01&rft.volume=28&rft.issue=11&rft.spage=5829&rft.epage=5839&rft.pages=5829-5839&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-021-09714-4&rft_dat=%3Cproquest_cross%3E2575670564%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2575670564&rft_id=info:pmid/33620616&rfr_iscdi=true |